Erlotinib Directly Inhibits HER2 Kinase Activation and Downstream Signaling Events in Intact Cells Lacking Epidermal Growth Factor Receptor Expression

Cancer Research - United States
doi 10.1158/0008-5472.can-06-3493
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

665. miR-7 Inhibits Schwannoma Tumor Growth by Directly Targeting P21-Activated Kinase 1 and Epidermal Growth Factor Receptor

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Activation of C-Fos Gene Expression by a Kinase-Deficient Epidermal Growth Factor Receptor.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1994English

Targeted Expression of Receptor-Associated Late Transducer Inhibits Maladaptive Hypertrophy via Blocking Epidermal Growth Factor Receptor Signaling

Hypertension
Internal Medicine
2009English

Parsing ERK Activation Reveals Quantitatively Equivalent Contributions From Epidermal Growth Factor Receptor and HER2 in Human Mammary Epithelial Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Epidermal Growth Factor Receptor-Targeted Photosensitizer Selectively Inhibits EGFR Signaling and Induces Targeted Phototoxicity in Ovarian Cancer Cells

Cancer Letters
Cancer ResearchOncology
2012English

The Serine/Threonine Kinase Cyclin G-Associated Kinase Regulates Epidermal Growth Factor Receptor Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Nordihydroguaiaretic Acid Inhibits an Activated Fibroblast Growth Factor Receptor 3 Mutant and Blocks Downstream Signaling in Multiple Myeloma Cells

Cancer Research
Cancer ResearchOncology
2008English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy